The increasing elderly population throughout the globe has brought increasing attention to osteoporosis, the most important cause osteoporotic vertebral compression fractures (OVCF).[@b1-asm-3-165],[@b2-asm-3-165] OVCF has a prevalence of more than 30% in the population older than 65 years.[@b3-asm-3-165] OVCF is associated with acute and chronic pain, progressive spinal deformity, a decreased quality of life, impaired physical function and increasing mortality.[@b4-asm-3-165]--[@b8-asm-3-165]

One method to treat OVCF is conservative non-surgical management (NSM) which consists of bed rest, use of painkillers, and bracing.[@b9-asm-3-165] However, NSM does not improve vertebral height[@b10-asm-3-165] or reverse kyphotic deformities, and has undesirable effects such as bedsores, bone demineralization and deep vein thrombosis. [@b11-asm-3-165] Since 1987, vertebroplasty (VP) and kyphoplasty (KP) with polymethylmethacrylate (PMMA) augmentation has been increasingly advocated as treatment for OVCF.[@b12-asm-3-165],[@b13-asm-3-165] Both of these minimally invasive techniques increase bone strength and reduce pain. Recently, two randomized controlled trials (RCT) showed that both methods were effective in reducing immediate pain, unlike conservative treatment.[@b14-asm-3-165],[@b15-asm-3-165] Several studies have shown that KP achieves better restoration of the kyphotic angle and vertebral height compared with VP[@b16-asm-3-165]--[@b18-asm-3-165] Furthermore, KP reduced the cement leakage rate compared with VP.[@b19-asm-3-165],[@b20-asm-3-165]

The comparative effectiveness and complications of KP and VP have been assessed in a few systematic reviews and meta-analysis, all which pooled randomized contolled trials with observational studies. This systematic review updates previous analyses.[@b21-asm-3-165]--[@b25-asm-3-165]

PATIENTS AND METHODS
====================

Literature search
-----------------

We performed a comprehensive systematic computer-based literature search of published reports before August 2015 in PubMed, EMBASE and the Cochrane Central Register of Controlled Trials (CENTRAL). The reference lists of the selected studies were also searched. The search terms were: "kyphoplasty" or "KP" AND "vertebroplasty" or "VP" AND "vertebral fracture" AND "osteoporotic" or "osteoporosis". We selected randomized controlled trials (RCTs) and prospective and retrospective cohort studies that compared KP with VP with no language restrictions. The protocol was not registered.

Inclusion/Exclusion criteria
----------------------------

The inclusion criteria were that studies be comparative studies (RCTs, prospective and retrospective cohort studies) comparing KP and VP in patients with OVCF. Outcomes had to include the postoperative time to injury, the duration of the operation, pain relief and quality of life, postoperative radiographic data and complications. Studies were excluded from our meta-analysis if they were of vertebral fractures caused by any etiology other than osteoporosis, including neoplastic or invasive, infective and traumatic fracture. Studies involving any type of cement other than PMMA cement were excluded.

Quality assessment and data extraction
--------------------------------------

RCTs were carefully assessed by two authors (LL and XLC) and any disagreement resolved through discussion. Determination of the risk of bias in the RCTs included the following key domains: adequate sequence generation, allocation concealment, blinding, incomplete outcome data, free from selective reporting, and free from other bias. The prospective and retrospective cohort studies were assessed by the methodological index for non-randomized studies (MINORS), a validated instrument designed to assess the quality of comparative or non-comparative non-RCT studies. LL and XLC independently extracted the data from each article with a standard data extraction form. The data included authors, year of publication, study design, age of population, gender, numbers of vertebral bodies, surgical procedures, duration of follow-up and outcomes parameters. The extracted data were analyzed by YYZ.

Clinical outcomes
-----------------

Pain intensity and functional disability was measured using the visual analog scale (VAS) and the Oswestry Disability Index (ODI). Radiographic outcomes included the height of the vertebral body (anterior, middle and posterior) and the kyphotic angle. Complication outcomes were cement leakage and new vertebral fracture. Injury time, operation time and the volume of injected cement were also extracted from the reports.

VAS and ODI were extracted and summarized by short-term (less than one week) and long-term (more than six months) follow-up. We defined the short-term period as less than one week and the long-term period as no less than 6 months.[@b25-asm-3-165] If there were several time points in the long-term follow-up, we selected the longest follow-up. We defined the postoperative period as the first day after surgery and improvement as any change between the preoperative and postoperative periods.

Complications
-------------

We classified cement leakage as any intraspinal and extraspinal leakage. Intraspinal leakage means that cement leaked into the intraspinal space, including the disc and vertebral body; if cement leaked into an extraspinal space such as the external venous plexus, epidural tissue or spinal canal, we considered that extraspinal leakage. Fractures included re-fracture of the same postoperative vertebral body and fractures of an adjacent vertebral body.

Statistical analysis
--------------------

We performed all meta-analysis with Stata version 12.0 (StataCorp, College Station, TX). For dichotomous outcomes, the odds ratio (OR) and the 95% confidence interval (95% CI) were assessed. For continuous outcomes, means and standard deviations were pooled to a weighted or standardized mean difference (WMD or SMD), a weighting by the individual variances for each study, and the 95% CI. A probability of *P*\<.05 was regarded as statistically significant. Statistical heterogeneity was assessed using Q statistics. Analysis of the outcomes was divided to subgroups according to the time or the region, if possible. For the variables - extraspinal and total leakage, adjacent and total new fracture, posterior height-postoperation, we used a fixed-effects model; for the rest, we used a random-effects model.

RESULTS
=======

Study characteristics
---------------------

Of 1300 titles and abstracts reviewed preliminarily, 32 met the inclusion criteria for the meta-analysis.[@b17-asm-3-165],[@b26-asm-3-165]--[@b56-asm-3-165] ([Figure 1](#f1-asm-3-165){ref-type="fig"}). They included 4 RCTs,[@b27-asm-3-165],[@b31-asm-3-165],[@b41-asm-3-165],[@b53-asm-3-165] 14 prospective cohort studiess,[@b17-asm-3-165],[@b32-asm-3-165],[@b33-asm-3-165],[@b36-asm-3-165],[@b39-asm-3-165],[@b40-asm-3-165],[@b41-asm-3-165]--[@b49-asm-3-165],[@b54-asm-3-165] and 14 retrospective cohort studies[@b26-asm-3-165],[@b28-asm-3-165]--[@b30-asm-3-165],[@b34-asm-3-165],[@b35-asm-3-165],[@b37-asm-3-165],[@b38-asm-3-165],[@b42-asm-3-165],[@b50-asm-3-165]--[@b52-asm-3-165],[@b55-asm-3-165],[@b56-asm-3-165] ([Figures 2](#f2-asm-3-165){ref-type="fig"} and [3](#f3-asm-3-165){ref-type="fig"}). There were a total of 3274 patients; 1653 patients underwent the KP surgery and 1621 underwent VP surgery. Individual study sample sizes ranged from 41 to 381 patients. The demographic characteristics of patients are summarized in [Table 1](#t1-asm-3-165){ref-type="table"}.

Clinical outcomes
-----------------

Eighteen studies reported short-term follow-up VAS scores.[@b17-asm-3-165],[@b28-asm-3-165],[@b30-asm-3-165],[@b31-asm-3-165],[@b33-asm-3-165],[@b35-asm-3-165],[@b36-asm-3-165],[@b38-asm-3-165]--[@b42-asm-3-165],[@b47-asm-3-165],[@b49-asm-3-165]--[@b52-asm-3-165],[@b55-asm-3-165] There was a significant difference between KP and VP (WMD=−0.2, 95% CI=−0.27 to −0.63; *P*\<.01). Long-term VAS scores were available from 14 studies.[@b17-asm-3-165],[@b28-asm-3-165],[@b30-asm-3-165],[@b32-asm-3-165],[@b35-asm-3-165],[@b36-asm-3-165],[@b38-asm-3-165],[@b41-asm-3-165],[@b45-asm-3-165],[@b47-asm-3-165],[@b49-asm-3-165],[@b51-asm-3-165] The pooled result also showed a significant difference between the two groups (WMD=−0.46, 95% CI=−0.57 to −0.36; *P*\<.01) ([Figure 4](#f4-asm-3-165){ref-type="fig"} and [Table 2](#t2-asm-3-165){ref-type="table"}). Adequate data on short-term ODI scores was present in 7 studies[@b17-asm-3-165],[@b31-asm-3-165],[@b35-asm-3-165],[@b38-asm-3-165],[@b39-asm-3-165],[@b47-asm-3-165],[@b50-asm-3-165] and the difference in overall estimate was statistically significant (WMD−17.56, 95% CI=−18.07 to −17.05; *P*\<.01). Eight studies provided long-term ODI data.[@b17-asm-3-165],[@b30-asm-3-165],[@b35-asm-3-165],[@b36-asm-3-165],[@b38-asm-3-165]--[@b40-asm-3-165],[@b47-asm-3-165] There was a significant difference between KP and VP (WMD=−2.41, 95% CI= −3.44 to −1.38; *P*\<.01) ([Figure 5](#f5-asm-3-165){ref-type="fig"} and [Table 2](#t2-asm-3-165){ref-type="table"}).

The dates of injury were available for four trials. [@b40-asm-3-165],[@b41-asm-3-165],[@b48-asm-3-165],[@b55-asm-3-165] The pooled results demonstrated no significant difference between the KP and VP group (WMD=−1.31, 95% CI=−3.37 to 0.75; *P*\<.01). Five reports reported the mean and standard deviation for operation time.[@b27-asm-3-165],[@b31-asm-3-165],[@b41-asm-3-165],[@b43-asm-3-165],[@b51-asm-3-165] VP required less time for the surgical procedure (WMD=6.58, 95% CI=5.47 to 7.68; *P*\<.01) than the KP group ([Table 2](#t2-asm-3-165){ref-type="table"}). The reported volume of injected cement analyzed in 12 studies[@b26-asm-3-165],[@b27-asm-3-165],[@b38-asm-3-165],[@b39-asm-3-165],[@b41-asm-3-165],[@b44-asm-3-165]--[@b46-asm-3-165],[@b52-asm-3-165],[@b53-asm-3-165],[@b55-asm-3-165],[@b56-asm-3-165] was greater in the KP group (WMD=0.51, 95% CI=0.44 to 0.56; *P*\<.01) ([Figure 6](#f6-asm-3-165){ref-type="fig"} and [Table 2](#t2-asm-3-165){ref-type="table"}).

Radiographic outcome
--------------------

In the 14 studies that reported the postoperative anterior height of the vertebral body,[@b17-asm-3-165],[@b26-asm-3-165],[@b28-asm-3-165],[@b30-asm-3-165],[@b35-asm-3-165],[@b36-asm-3-165],[@b41-asm-3-165],[@b43-asm-3-165],[@b47-asm-3-165],[@b48-asm-3-165],[@b50-asm-3-165]--[@b53-asm-3-165] there was a significant difference in the immediate postoperative follow-up period (WMD=2.55, 95% CI=2.33 to 2.78, *P*\<.01), the final follow-up (WMD=2.79, 95% CI=2.39 to 3.19; *P*\<.01) and improvement (WMD=5.91, 95% CI=5.19 to 6.64; *P*=\<.01) between the KP and VP groups, respectively. Patients who underwent the KP procedure had a better post-operative anterior height of the vertebral body than those who had the VP procedure ([Table 3](#t3-asm-3-165){ref-type="table"}).

The pooled measures of middle height included the immediate postoperative follow-up period (WMD=2.44, 95% CI=2.14 to 2.73; *P*\<.01) and the final follow-up (WMD=6.92, 95% CI=6.31 to 7.52; *P*\<.01) in four[@b17-asm-3-165],[@b35-asm-3-165],[@b43-asm-3-165],[@b45-asm-3-165] and three studies,[@b17-asm-3-165],[@b35-asm-3-165],[@b43-asm-3-165] respectively. Both showed a significant difference and demonstrated that the KP group had a better result than the VP group for changes in anterior and middle vertebral height, but in three reports there was no significant difference in pooled posterior height between KP and VP[@b28-asm-3-165],[@b43-asm-3-165],[@b47-asm-3-165] (WMD=0.5, 95% CI=−0.03 to 1.02; *P*=.178/WMD=1.78, 95% CI=1.44 to 2.11; *P*=.033) ([Table 3](#t3-asm-3-165){ref-type="table"}).

The kyphotic angle in the immediate postoperative was analyzed in 15 studies.[@b17-asm-3-165],[@b28-asm-3-165],[@b33-asm-3-165],[@b35-asm-3-165],[@b38-asm-3-165],[@b40-asm-3-165],[@b41-asm-3-165],[@b44-asm-3-165],[@b47-asm-3-165],[@b49-asm-3-165]--[@b53-asm-3-165],[@b56-asm-3-165] The kyphotic angle improved more in the KP group than in the VP group (WMD=−2.5, 95% CI=−2.84 to −2.16; *P*\<.01). Nine studies[@b17-asm-3-165],[@b28-asm-3-165],[@b35-asm-3-165],[@b38-asm-3-165],[@b40-asm-3-165],[@b47-asm-3-165],[@b49-asm-3-165],[@b51-asm-3-165],[@b56-asm-3-165] reported the kyphotic angle at the final follow-up (WMD=−1.7, 95%CI=−2.06 to −1.33; *P*\<.01) and seven studies[@b29-asm-3-165],[@b30-asm-3-165],[@b44-asm-3-165],[@b49-asm-3-165],[@b52-asm-3-165],[@b53-asm-3-165],[@b55-asm-3-165] compared the improvement (WMD=4.76, 95%CI=4.19 to 5.32; *P*\<.01). With the KP procedure there was more improvement in the kyphotic angle than with the VP procedure ([Figure 7](#f7-asm-3-165){ref-type="fig"} and [Table 3](#t3-asm-3-165){ref-type="table"}).

Complications
-------------

Cement leakage in the VP group was significantly more frequent than in the KP group in the intraspinal space (OR=0.5, 95% CI=0.3 to 0.85; *P*=.035)[@b31-asm-3-165],[@b32-asm-3-165],[@b34-asm-3-165],[@b36-asm-3-165],[@b37-asm-3-165],[@b40-asm-3-165],[@b43-asm-3-165]--[@b45-asm-3-165],[@b47-asm-3-165],[@b48-asm-3-165],[@b52-asm-3-165],[@b55-asm-3-165] in the extraspinal space (OR=0.36, 95% CI=0.21 to 0.62; *P*=.15)[@b31-asm-3-165],[@b32-asm-3-165],[@b34-asm-3-165],[@b36-asm-3-165],[@b37-asm-3-165],[@b40-asm-3-165],[@b43-asm-3-165],[@b45-asm-3-165],[@b47-asm-3-165]--[@b49-asm-3-165],[@b52-asm-3-165] and in total leakage (OR=0.53, 95% CI=0.4 to 0.7; *P*=.051) ([Figure 8](#f8-asm-3-165){ref-type="fig"} and [Table 4](#t4-asm-3-165){ref-type="table"}).[@b26-asm-3-165],[@b27-asm-3-165],[@b30-asm-3-165]--[@b32-asm-3-165],[@b34-asm-3-165]--[@b36-asm-3-165],[@b39-asm-3-165],[@b40-asm-3-165],[@b40-asm-3-165]--[@b45-asm-3-165],[@b47-asm-3-165]--[@b53-asm-3-165],[@b55-asm-3-165],[@b57-asm-3-165] Thirteen studies reported complications related to fractures.[@b26-asm-3-165],[@b34-asm-3-165]--[@b36-asm-3-165],[@b39-asm-3-165]--[@b41-asm-3-165],[@b43-asm-3-165]--[@b45-asm-3-165],[@b47-asm-3-165],[@b52-asm-3-165],[@b54-asm-3-165] The pooled analysis showed no significant difference between the KP and VP group (OR=0.94, 95% CI=0.59 to 1.49; *P*=.248). Of these, there were nine reports of adjacent fractures.[@b26-asm-3-165],[@b34-asm-3-165],[@b36-asm-3-165],[@b39-asm-3-165],[@b41-asm-3-165],[@b43-asm-3-165]--[@b45-asm-3-165],[@b47-asm-3-165] There was no significant difference between the groups (OR=1.41, 95% CI=0.7 to 2.83; *P*=.283) ([Table 4](#t4-asm-3-165){ref-type="table"}).

DISCUSSION
==========

Our systematic review and meta-analysis included 4 randomized studies and 28 non-randomized studies that included 1653 patients treated with KP and 1621 patients treated with VP. The main outcome variables were pain intensity and dysfunction measured by VAS and ODI, kyphotic angle, and vertebral height at short-term and long-term follow-ups. Postoperative complications included new vertebral and adjacent fractures, as well as time of injury and duration of surgery.

Treatment of OVCF should lead to a lasting improvement in the pain. More than 90% of pain and dysfunction caused by OVCF can be relieved successfully by KP or VP. Both surgical procedures significantly relieve the pain and improved dysfunction in patients with OVCF. In our analysis, KP was more effective on the VAS and ODI assessments than the VP group. The mechanism of pain reduction reflected in Oswestry score improvements might result from the inhibition and immobility of micro-movements of the fractured vertebral body, as well as the cytotoxic effect of the PMMA cement.[@b57-asm-3-165]--[@b59-asm-3-165]

We pooled the improvement in kyphotic angle and height, which included the anterior, middle and posterior vertebral body. Improvements in postoperative anterior and middle height were better in the KP group in the immediate postoperative period and at the final follow-up. Improvements in posterior height were similar. One study reported that a reduction in the kyphotic angle depends more on natural healing than surgical treatment.[@b60-asm-3-165] Schofer et al[@b49-asm-3-165] reported a reduction in the kyphotic angle by a mean of 3--6° after the KP procedure compared with a reduction of 1°, suggesting that the balloon-induced restoration had a positive effect.

Total new vertebral fracture did not differ between the KP and VP groups. There was also no difference in the rate of adjacent fractures. Whether bone cement injection causes an increased incidence of new vertebral fractures is an interesting topic of ongoing discussion. Hulme et al[@b20-asm-3-165] showed that the incidence of new vertebral fractures did not increase in osteoporotic patients who had suffered vertebral fractures. New vertebral fractures may relate to the sustained loss of bone mass seen in the osteoporotic population, rather than the surgical procedure itself.

Cement leakage does not usually result in clinical symptoms. In our experience, the high injection pressure and low viscidity of the cement leads to a higher incidence of cement leakage during VP than during KP. The KP procedure creates a hole in which to package the cement with the help of a balloon. The KP group had a lower frequency of leakage than the VP group in our analysis. The intraspinal and extraspinal leakage were greater in the VP group.

An ideal meta-analysis would include only RCTs with little heterogeneity. However, RCTs are rare for surgical procedures. Patients will not usually agree to partake in a randomized surgical option. Every surgeon has his personal specialty and chooses the preferable procedure according to the specific condition. Because of the lack of RCTs, we included prospective and retrospective cohort studies of high quality and designed a baseline form to collect demographic characteristics in a manner that would limit the risk of bias.

In conclusion, we found that the KP procedure was more effective in pain relief, physical functional improvement, improving restoration of vertebral height and kyphotic angle with reduced cement leakage, but the KP surgery took longer and required a greater volume of injected cement. The KP procedure has a higher cost of hospitalization. Additional RCTs are needed to confirm these conclusions and to select the best surgical procedure for patients with OVCF.
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###### 

Patient demographic and study characteristics of the 32 studies in the meta-analysis.

  Study                               Country         Year   Study design    Patient numbers   Age (years)   Follow-up period (KP/VP) (months)   MINORS scores               
  ----------------------------------- --------------- ------ --------------- ----------------- ------------- ----------------------------------- --------------- ----------- ----
  Bozkurt et al[@b26-asm-3-165]       Turkey          2014   Retrospective   200               96            57.5                                57              40          14
  Dohm et al[@b27-asm-3-165]          United States   2014   RCT             191               190           75.6                                                24          \-
  Dong et al[@b28-asm-3-165]          China           2013   Retrospective   51                35            69.8                                70.5            21.3        14
  Dong et al[@b29-asm-3-165]          China           2009   Retrospective   20                18            69.5                                70.2            3           11
  Ee et al[@b30-asm-3-165]            England         2012   Retrospective   97                148           75                                  77              24          15
  Endres et al[@b31-asm-3-165]        Germany         2011   RCT             20                21            63.3                                71.3            5.8         \-
  Figueiredo et al[@b32-asm-3-165]    Brazil          2011   Prospective     22                30            73                                  77              6           16
  Folman et al[@b33-asm-3-165]        Israel          2011   Prospective     31                14            70.7                                75.6            12          16
  Frankel et al[@b34-asm-3-165]       United States   2007   Retrospective   17                29            70                                  72              3.5 years   14
  Gan et al[@b35-asm-3-165]           China           2014   Retrospective   41                38            69.1                                67.1            43.5/41.4   15
  Grohs et al[@b36-asm-3-165]         Austria         2005   Prospective     28                23            70                                  70              24          17
  Hiwatashi et al[@b37-asm-3-165]     Japan           2008   Retrospective   40                66            75                                  77              NR          13
  Kong et al[@b38-asm-3-165]          China           2014   Retrospective   29                24            71.9                                70.5            12          13
  Kumar et al[@b39-asm-3-165]         Canada          2009   Prospective     24                28            73                                  78              42.3/42.2   17
  Li et al[@b40-asm-3-165]            China           2012   Prospective     45                40            68.5                                67.1            12          17
  Liu JT et al[@b41-asm-3-165]        Taiwan          2009   RCT             50                50            72.3                                74.3            \>6         \-
  Liu T et al[@b42-asm-3-165]         China           2013   Retrospective   40                60            68.5                                62.5            1 week      13
  Lovi et al[@b43-asm-3-165]          Italy           2009   Prospective     36                118           67.6                                33m             17          
  Movrin et al[@b44-asm-3-165]        Slovenia        2010   Prospective     46                27            67.8                                72.9            1 year      16
  Omidi-Kashani[@b45-asm-3-165]       Iran            2013   Prospective     29                28            72.1                                72.4            6m          13
  Pflugmacher et al[@b17-asm-3-165]   Germany         2005   Prospective     22                20            67                                  65              12          15
  Qian et al[@b46-asm-3-165]          China           2012   Prospective     53                9             66.2                                3.9y            16          
  Rollinghoff et al[@b47-asm-3-165]   Germany         2009   Prospective     53                51            68.9                                1y              17          
  Santiago et al[@b48-asm-3-165]      Span            2009   Prospective     30                30            65.9                                73              1 year      16
  Schofer et al[@b49-asm-3-165]       Germany         2009   Prospective     30                30            72.5                                73.8            13.5/13.7   17
  Sun et al[@b50-asm-3-165]           China           2010   Retrospective   31                28            74.2                                72.3            18          14
  Wu et al[@b51-asm-3-165]            China           2014   Retrospective   20                20            65.1                                66.3            1 year      15
  Yan et al[@b52-asm-3-165]           China           2011   Retrospective   98                94            76.9                                77.2            14.3/15.2   14
  Yang et al[@b53-asm-3-165]          Korea           2014   RCT             112               109           73.4                                73.3            NR          \-
  Yi et al[@b54-asm-3-165]            China           2014   Prospective     79                90            61.3                                49.4m           16          
  Yokoyama et al[@b55-asm-3-165]      Japan           2013   Retrospective   38                28            75.5                                74              NR          12
  Zhang et al[@b56-asm-3-165]         China           2013   Retrospective   30                29            68.7                                66.2            25          13

NR = not reported. RCT = randomized controlled trial. Follow-up period is months unless reported otherwise.

The MINORS criteria include the following items: (1) a clearly stated aim; (2) inclusion of consecutive patients; (3) Prospective data collection; (4) endpoints appropriate to the aim of the study; (5) unbiased assessment of the study endpoint; (6) a follow-up period appropriate to the aims of the study; (7) less than 5% loss to follow-up; (8) Prospective calculation of the sample size; (9) an adequate control group; (10) contemporary groups; (11) baseline equivalence of groups; and (12) adequate statistical analysis. The items are scored as follows: 0 (not reported); 1 (reported but inadequate); 2 (reported and adequate). The ideal global score for comparative studies is 24.

###### 

Meta-analysis of clinical outcomes comparing the KP and VP groups.

  Outcomes                        No. of studies   No. of patients   Effect estimate (95% CI)   *P*
  ------------------------------- ---------------- ----------------- -------------------------- -------
  **Visual analog scale**                                                                       
   Short-term                     18               1500              −0.2 (−0.27, −0.13)        \<.01
   Long-term                      14               1071              −0.46 (−0.57, −0.36)       \<.01
  **Oswestry Disability Index**                                                                 
   Short-term                     7                430               −17.56 (−18.07,−17.05)     \<.01
   Long-time                      8                676               −2.41 (−3.44, −1.38)       \<.01
  Injury time                     4                311               −1.31 (−3.37, 0.75)        \<.01
  Operation time                  5                716               6.58 (5.47, 7.68)          \<.01
  Volume of injected cement       12               1764              0.51 (0.44, 0.56)          \<.01

The effect estimate is weighted mean difference, CI=confidence interval.

###### 

Results of meta-analysis of radiological outcome measures.

  Outcomes                  No. of studies   No. of patients   Effect estimate (95% CI)   *P*
  ------------------------- ---------------- ----------------- -------------------------- -------
  **Anterior height**                                                                     
  Postoperative follow-up   10               1020              2.55 (2.33, 2.78)          \<.01
  Final follow-up           6                505               2.79 (2.39, 3.19)          \<.01
  Improvement               4                797               5.91 (5.19, 6.64)          \<.01
  **Middle height**                                                                       
  Postoperative follow-up   4                386               2.44 (2.14, 2.73)          \<.01
  Final follow-up           3                275               6.92 (6.31, 7.52)          \<.01
  **Posterior height**                                                                    
  Postoperative follow-up   3                344               0.5 (−0.03, 1.02)          .178
  Final follow-up           3                344               1.78 (1.44, 2.11)          .033
  **Kyphotic angle**                                                                      
  Postoperative follow-up   15               1365              −2.5 (−2.84, −2.16)        \<.01
  Final follow-up           9                641               −1.7 (−2.06, −1.33)        \<.01
  Improvement               7                916               4.79 (4.19, 5.32)          \<.01

Effect estimates are weighted mean difference, CI = confidence interval, postoperative means immediate postoperative follow-up period.

###### 

Differences in complications between the VP and K groups.

  Outcomes            No. of studies   No. of patients   Effect estimate (95% CI)   *P*
  ------------------- ---------------- ----------------- -------------------------- ------
  **Leakage**                                                                       
  Intraspinal         13               1503              0.5 (0.3, 0.85)            .035
  Extraspinal         12               1223              0.36 (0.21,0.62)           .15
  Total               22               2773              0.53 (0.4, 0.7)            .051
  **New fractures**                                                                 
  Adjacent            9                1070              1.41 (0.7, 2.83)           .283
  Total               13               1628              0.94 (0.59, 1.49)          .248

Effect estimates are weighted mean difference, CI = confidence interval.

[^1]: Both authors equally contributed to this study.
